English Polski
Vol 11, No 5 (2016)
Cardiology Investigation
Published online: 2016-11-22

open access

Page views 929
Article views/downloads 2361
Get Citation

Connect on Social Media

Connect on Social Media

Echocardiographic parameters helpful in qualification for MitraClip surgery

Monika Budnik
Folia Cardiologica 2016;11(5):487-490.

Abstract

Currently, the best method of treatment of mitral regurgitation is the surgical correction (valve repair or replacement). However, because of the coexisting comorbidities alternative therapies are sought. One technique for percutaneous treatment of mitral regurgitation is applying the MitraClip system.

Article available in PDF format

View PDF (Polish) Download PDF file

References

  1. Vahanian A, Otto CM, Iung B, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003; 24(13): 1231–1243.
  2. Vahanian A, Alfieri O, Andreotti F, et al. ESC Committee for Practice Guidelines (CPG), Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC), European Association for Cardio-Thoracic Surgery (EACTS), Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC), European Association for Cardio-Thoracic Surgery (EACTS). Guidelines on the management of valvular heart disease (version 2012). Eur Heart J. 2012; 33(19): 2451–2496.
  3. De Bonis M, Lapenna E, La Canna G, et al. Mitral valve repair for functional mitral regurgitation in end-stage dilated cardiomyopathy: role of the "edge-to-edge" technique. Circulation. 2005; 112(9 Suppl): I402–I408.
  4. Feldman T, Kar S, Elmariah S, et al. EVEREST II Investigators. Randomized Comparison of Percutaneous Repair and Surgery for Mitral Regurgitation: 5-Year Results of EVEREST II. J Am Coll Cardiol. 2015; 66(25): 2844–2854.
  5. Glower DD, Kar S, Trento A, et al. Percutaneous mitral valve repair for mitral regurgitation in high-risk patients: results of the EVEREST II study. J Am Coll Cardiol. 2014; 64(2): 172–181.
  6. Zamorano J, Gonçalves A, Lancellotti P, et al. EACVI reviewers:. The use of imaging in new transcatheter interventions: an EACVI review paper. Eur Heart J Cardiovasc Imaging. 2016; 17(8): 835–835af.
  7. Maisano F, Franzen O, Baldus S, et al. Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. J Am Coll Cardiol. 2013; 62(12): 1052–1061.
  8. Schillinger W, Hünlich M, Baldus S, et al. Acute outcomes after MitraClip therapy in highly aged patients: results from the German TRAnscatheter Mitral valve Interventions (TRAMI) Registry. EuroIntervention. 2013; 9(1): 84–90.
  9. O'Gara P, Sugeng L, Lang R, et al. The role of imaging in chronic degenerative mitral regurgitation. JACC Cardiovasc Imaging. 2008; 1(2): 221–237.
  10. Boekstegers P, Hausleiter J, Baldus S, et al. Germany Society of Cardiology Working Group on Interventional Cardiology Focus Group on Interventional Mitral Valve Therapy. Percutaneous interventional mitral regurgitation treatment using the Mitra-Clip system. Clin Res Cardiol. 2014; 103(2): 85–96.
  11. Willson AB, Rodès-Cabau J, Wood DA, et al. Transcatheter aortic valve replacement with the St. Jude Medical Portico valve: first-in-human experience. J Am Coll Cardiol. 2012; 60(7): 581–586.
  12. Herrmann HC, Kar S, Siegel R, et al. EVEREST Investigators. Effect of percutaneous mitral repair with the MitraClip device on mitral valve area and gradient. EuroIntervention. 2009; 4(4): 437–442.